Breaking Barriers: ANDYSMANCLUB’s Fight for Men’s Mental Health

News Medical Spoke with Luke Tetlow-Cross, a project development champion for a mental health charity called ANDYSMANCLUB.

Glox Therapeutics to develop precision antibiotics for cystic fibrosis

More than 162,000 people worldwide are estimated to be living with CF. Credit: Orawan Pattarawimonchai/Shutterstock. Glox Therapeutics is set to receive a share of the

January 22, 2025

Danish biotech gears up for Phase IIb hidradenitis suppurativa trial following early clinical results

MC2 Therapeutics’ drug candidate for hidradenitis suppurativa has shown hints of efficacy potential in a Phase IIa trial, sparking plans for Phase IIb development with

October 12, 2023

Current PSA monitoring guidelines may lead to overtreatment after prostate surgery

After surgical removal of the prostate to treat prostate cancer, clinicians monitor Prostate Specific Antigen (PSA) levels.

March 13, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.